Pharmacokinetics, Pharmacodynamics, and Safety of Canagliflozin in Japanese Patients with Type 2 Diabetes Mellitus

INTRODUCTION: Canagliflozin is a sodium glucose co-transporter 2 inhibitor approved worldwide for the treatment of patients with type 2 diabetes mellitus (T2DM). The present study evaluated pharmacokinetics, pharmacodynamics, and safety of canagliflozin in Japanese patients with T2DM. METHODS: Canag...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Adv Ther
Main Authors: Iijima, Hiroaki, Kifuji, Takayuki, Maruyama, Nobuko, Inagaki, Nobuya
Format: Artigo
Jezik:Inglês
Izdano: Springer Healthcare 2015
Teme:
Original Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4569680/
https://ncbi.nlm.nih.gov/pubmed/26280756
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-015-0234-0
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki